Skip to main content
. 2009 Feb;11(2):205–213. doi: 10.1093/eurjhf/hfn029

Table 1.

Baseline characteristics

Exercise arm (n = 84) Control arm (n = 85)
Sex, n (%)
 Males 64 (76.2) 62 (72.9)
 Females 20 (23.8) 23 (27.1)
NYHA on recruitment, n (%)
 I 4 (4.8) 6 (7.1)
 II 63 (75.0) 62 (72.9)
 III 17 (20.0) 17 (20.0)
AF present on recruitment, n (%) 17 (20.2) 18 (21.2)
Age, mean (SD) 65.9 (12.5) 70.0 (12.5)
Ethnicity, n (%)
 White 69 (83.1) 74 (87.1)
 South Asian 5 (6.0) 5 (5.9)
 Other 9 (10.8) 6 (7.1)
Past medical history, n (%)
 Diabetes 18 (21.4) 19 (22.4)
 Stroke 8 (9.5) 7 (8.2)
 Peripheral vascular disease 7 (8.3) 7 (8.2)
 Angina 34 (40.5) 36 (42.4)
 Hypertension 30 (35.7) 38 (44.7)
 Valvular heart disease 14 (16.7) 19 (22.4)
 Myocardial infarction 40 (47.6) 33 (38.8)
 CABG 16 (19.0) 10 (11.8)
 Angioplasty 15 (17.9) 14 (16.5)
 Attended cardiac rehabilitation 14 (16.7) 10 (11.8)
In paid employment, n (%) 7 (8.3) 4 (4.7)
Years in full-time education, mean (SD) 10.9 (3.7) 10.6 (2.2)
Current smoker, n (%) 7 (8.3) 8 (9.4)
Units of alcohol/week, mean (SD) 5.85 (8.0) 5.23 (8.7)
MLwHFQ score, mean (SD) 33.35 (21.3) 31.82 (22.5)
ISWT distance (m), mean (SD) 234.0 (132.6) 220.5 (130.7)
Self-reported physical activity score, mean (SD) 4.55 (2.5) 4.67 (2.6)
HADS anxiety score, mean (SD) 6.05 (4.36) 5.48 (4.07)
HADS depression score, mean (SD) 6.27 (3.58) 5.01 (3.07)
EQ5D, mean (SD) 0.675 (0.25) 0.696 (0.26)
SBP (mmHg), mean (SD) 116.63 (15.6) 124.0 (19.7)
DBP (mmHg), mean (SD) 67.85 (10.8) 68.29 (12.4)
Drugs, n (%)
 Diuretic 77 (92.8) 78 (91.8)
 ACE-inhibitor or A-II receptor antagonists 82 (98.8) 80 (94.1)
 Beta-blockers 61 (73.5) 52 (61.2)

NYHA, New York Heart Association class; AF, atrial fibrillation; CABG, coronary artery bypass graft; MLwHFQ, Minnesota Living with Heart Failure Questionnaire; ISWT, incremental shuttle walking test; HADS, Hospital Anxiety and Depression Scale; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE, angiotensin-converting enzyme; A-II, angiotensin II receptor blocker.